These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3827555)

  • 21. Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.
    Mendell JR; Griggs RC; Moxley RT; Fenichel GM; Brooke MH; Miller JP; Province MA; Dodson WE
    Muscle Nerve; 1984 Sep; 7(7):535-41. PubMed ID: 6399927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic heterogeneity in Duchenne dystrophy.
    Hyser CL; Province M; Griggs RC; Mendell JR; Fenichel GM; Brooke MH; Miller JP; Polakowska R; Doherty RA; Quirk S
    Ann Neurol; 1987 Oct; 22(4):553-5. PubMed ID: 3435074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic arm study: quantitative description of upper extremity function and activity of boys and men with duchenne muscular dystrophy.
    Janssen MMHP; Harlaar J; Koopman B; de Groot IJM
    J Neuroeng Rehabil; 2017 May; 14(1):45. PubMed ID: 28549441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hand weakness in Duchenne muscular dystrophy and its relation to physical disability.
    Mattar FL; Sobreira C
    Neuromuscul Disord; 2008 Mar; 18(3):193-8. PubMed ID: 18207403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between height and clinical course in Duchenne muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Rocha JM; Pavanello Rde C; Colletto GM; Peres CA
    Am J Med Genet; 1988 Feb; 29(2):405-10. PubMed ID: 3354613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II.
    Werlauff U; Fynbo Steffensen B
    Disabil Rehabil; 2014; 36(25):2120-6. PubMed ID: 24579651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiorespiratory function in Duchenne and Becker muscular dystrophy.
    Taşdemir HA; Cil E; Topaloğlu H; Yalaz K; Aysun S; Renda Y; Ozme S
    Turk J Pediatr; 1996; 38(3):307-14. PubMed ID: 8827899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of spinal fusion on respiratory function and quality of life in Duchenne muscular dystrophy].
    Matsumura T; Kang J; Nozaki S; Takahashi MP
    Rinsho Shinkeigaku; 1997 Feb; 37(2):87-92. PubMed ID: 9164137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macroemg in manifesting carriers of Duchenne muscular dystrophy.
    Szmidt-Sałkowska E; Rowiñska-Marciñska K; Fidziañska A; Hausmanowa-Petrusewicz I
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):87-92. PubMed ID: 10207677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duchenne muscular dystrophy: unusual activation of single fibers in vitro.
    Takagi A; Nonaka I
    Muscle Nerve; 1981; 4(1):10-5. PubMed ID: 7231441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper extremity strength and function in children with spinal muscular atrophy type II.
    Koch BM; Simenson RL
    Arch Phys Med Rehabil; 1992 Mar; 73(3):241-5. PubMed ID: 1543427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limb girdle muscular dystrophy: weakness and disease duration as predictors of functional impairment.
    Stübgen JP; Lahouter A
    Muscle Nerve; 1994 Aug; 17(8):873-80. PubMed ID: 8041394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standing balance in healthy boys and in children with Duchenne muscular dystrophy.
    Kelly CR; Redford JB; Zilber S; Madden PA
    Arch Phys Med Rehabil; 1981 Jul; 62(7):324-7. PubMed ID: 7247659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.
    Brooke MH; Fenichel GM; Griggs RC; Mendell JR; Moxley R; Miller JP; Province MA
    Muscle Nerve; 1983 Feb; 6(2):91-103. PubMed ID: 6343858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy.
    Yotsukura M; Fujii K; Katayama A; Tomono Y; Ando H; Sakata K; Ishihara T; Ishikawa K
    Am Heart J; 1998 Aug; 136(2):289-96. PubMed ID: 9704692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of gait and movement of upper limbs in muscular dystrophies].
    Moreno Izco F; Mendioroz Iriarte M; Poza Aldea JJ; Martí Massó JF; López de Munain A
    Neurologia; 2005 Sep; 20(7):341-8. PubMed ID: 16163577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indicators for an impending need of artificial respiration in patients with muscular dystrophy].
    Lyager S; Steffensen B; Juhl B
    Ugeskr Laeger; 1993 Jun; 155(25):1963-7. PubMed ID: 8317062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy.
    Emeryk-Szajewska B; Kopeć J
    Electromyogr Clin Neurophysiol; 2008; 48(6-7):279-84. PubMed ID: 18837193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of patients with Duchenne muscular dystrophy receiving ventilatory support.
    Fukunaga H; Okubo R; Moritoyo T; Kawashima N; Osame M
    Muscle Nerve; 1993 May; 16(5):554-8. PubMed ID: 8515763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy].
    Kashiwagi S; Akaike M; Kawai H; Adachi K; Saito S
    Rinsho Shinkeigaku; 1996 Jan; 36(1):7-11. PubMed ID: 8689797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.